22.12.2024
... weekly performance: -5.45% Valneva: Austrian/French Valneva, a specialty vaccine company ... license agreement for Valneva’s single-shot chikungunya ...
21.12.2024
... -8,58% , Baxter International -9,29% , Valneva -9,84% , Evotec -12,63% , ... Baxter International mit +2,63% , Valneva mit +1,51% , Biogen Idec mit ...
21.12.2024
... Holding BABA 82.28 -2.41% Valneva VLA 1.924 -3.99% Ahlers AAH ...
20.12.2024
... . Manz M5Z 1.67 122.67% Valneva VLA 2.004 9.57% Zumtobel ZAG ...
19.12.2024
... 19,34, -0,72%) Valneva und der Impfstoffhersteller Serum Institute ... Preparedness Innovations (CEPI) unterzeichnet hat. Valneva ( Akt. Indikation: 1,86 ...
19.12.2024
... (CEPI) unterzeichnet hat. Valneva wird seinen Wirkstoff für den ... behördlichen Genehmigungen an Valneva vorsieht, teilt Valneva mit. Thomas Lingelbach ...
19.12.2024
... 3.34% Uniqa UQA 7.75 3.06% Valneva VLA 1.829 2.93% Lenzing LNZ ...
08.12.2024
... at EUR 2,80 per share. Valneva: Valneva SE, a specialty vaccine company, ... its unpredictable and explosive nature. Valneva: weekly performance: 4.61% ( ...
08.12.2024
... results are in line with Valneva’s expectations for this vaccine, confirming ... , the primary endpoint was met. Valneva: weekly performance: 4.61% UBM: ...
07.12.2024
... Perf. Ahlers AAH 0.008 7.14% Valneva VLA 1.93 5.35% Varta AG ...